Ausgabe 3/2020
Inhalt (11 Artikel)
Japanese Clinical Practice Guideline for Diabetes 2019
Eiichi Araki, Atsushi Goto, Tatsuya Kondo, Mitsuhiko Noda, Hiroshi Noto, Hideki Origasa, Haruhiko Osawa, Akihiko Taguchi, Yukio Tanizawa, Kazuyuki Tobe, Narihito Yoshioka
Medical nutrition therapy and dietary counseling for patients with diabetes-energy, carbohydrates, protein intake and dietary counseling
Toshimasa Yamauchi, Hideki Kamiya, Kazunori Utsunomiya, Hirotaka Watada, Daiji Kawanami, Junko Sato, Munehiro Kitada, Daisuke Koya, Norio Harada, Kenichiro Shide, Erina Joo, Ryo Suzuki, Ryotaro Bouchi, Yasuharu Ohta, Tatsuya Kondo
Ethics and practical mitigations for ongoing clinical trials during the COVID-19 pandemic
Shota Suzuki, Yukie Ito, Shu Kasama, Takashi Murata, Munehide Matsuhisa, Masato Kasahara
Current understanding of the effect of sodium–glucose co-transporter-2 inhibitors in Asian patients with diabetes mellitus
Hirotaka Watada
Significance of SGLT2 inhibitors: lessons from renal clinical outcomes in patients with type 2 diabetes and basic researches
Munehiro Kitada, Taro Hirai, Daisuke Koya
Promising roles of sodium–glucose cotransporter 2 inhibitors in heart failure prevention and treatment
Atsushi Tanaka, Koichi Node
Work-related, personal, and diabetes-related factors relevant to dropout from outpatient diabetes treatment visits among Japanese male employees with diabetes
Nao Sonoda, Soichiro Watanabe, Yuko Ohno, Kayo Godai, Chieko Hatamochi, Yoshie Sugimoto, Satoko Okawa, Maiko Shikama, Akiko Morimoto
Pathophysiology of gestational diabetes mellitus in lean Japanese pregnant women in relation to insulin secretion or insulin resistance
Shigeru Inoue, Yutaka Kozuma, Michio Miyahara, Toshiyuki Yoshizato, Yuji Tajiri, Daizo Hori, Kimio Ushijima
Efficacy and safety of a combination of an insulin secretagogue and a dipeptidyl peptidase-4 inhibitor in Japanese patients with type 2 diabetes mellitus; the repaglinide glucose oscillation study in Fukuoka (REGO-F)
Yuichi Terawaki, Chikayo Iwaya, Takashi Nomiyama, Dai Shimono, Tsuyoshi Horikawa, Yuki Fujimura-Tanaka, Toru Shigeoka, Nobuya Hamanoue, Ryoko Motonaga, Makito Tanabe, Toshihiko Yanase, Daiji Kawanami
Turkish version of the Michigan Neuropathy Screening Instrument in the assessment of diabetic peripheral neuropathy: a validity and reliability study
Serdar Kaymaz, Hakan Alkan, Ugur Karasu, Veli Çobankara
Plasma lipopolysaccharide binding protein level statistically mediates between body mass index and chronic microinflammation in Japanese patients with type 1 diabetes
Hirotaka Watanabe, Takashi Katsura, Mitsuyoshi Takahara, Kazuyuki Miyashita, Naoto Katakami, Taka-aki Matsuoka, Dan Kawamori, Iichiro Shimomura